Article Details
Retrieved on: 2024-06-27 14:31:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WATERTOWN, Mass., June 27, 2024 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to ...
Article found on: www.citybiz.co
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here